TickerFiles

bioAffinity Technologies, Inc. 10-Q filing

Filed 2025-11-14 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001493152-25-023405
Form type
10-Q
CIK
0001712762
Primary document
https://www.sec.gov/Archives/edgar/data/1712762/000149315225023405/form10-q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for bioAffinity Technologies, Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$4.6M--
Operating Income$-7.4M--
Net Income$-11.8M--
Eps Basic-7.55--
Eps Diluted-7.55--
Cash And Equivalents$7.7M--
Total Assets$11.5M--
Total Liabilities$2.6M--
Shareholders Equity$8.9M--
Operating Cash Flow$-6.8M--
Capital Expenditures$60,567--